The cancer prevention drug, tamoxifen, may cause cancer. It has been reported that rare cancers are being found in long-term users. Tamoxifen is the drug of choice, prescribed after breast cancer detection or surgery. Its use is deemed to have a 20% success rate in preventing further incidences of cancer. For this reason, many breast cancer survivors are long term users of tamoxifen, and this news is disturbing for both them and their caregivers.
Tamoxifen is an estrogen-blocking drug. The tumors that developed in the tamoxifen users were rare but aggressive. Some suggest that the risks still outweigh the downside, because tamoxifen is so successful at preventing a recurrence of common breast tumors
Many question the report and its methodology, which is the typical reaction from the medical community to bad news. And this is especially bad news, as tamoxifen is a staple in the fight against cancer.
The report about tamoxifen was not based on a research study, but only on observation. However the observation was made at the esteemed Fred Hutchinson Cancer Research Center in Seattle, WA, a center long known for comprehensive scientific research and reporting. The report was published inCancer Research. According the Dr. Li, the author of the report, long term tamoxifen usage increases risk by four-fold for a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor.
This report follows previously published findings by Dr. Li in 2001, in which the same findings were reported. At that time, Dr. Li found a fivefold increased risk of estrogen-receptor (ER)-negative breast cancers in breast cancer survivors taking tamoxifen. The 2001 study contained 9,000 women over the age of 50. They were followed from 1990 and 1999. All of the women lived in Western Washington State and this study was the first population-based study that looked at the estrogen-receptors in contralateral (opposite side of the body) breast tumors.
The use of tamoxifen has been shown to reduce by 20% the ER-positive contralateral breast cancers - the most common type. This type of cancer is found in two-thirds of the cases diagnosed. Now that findings show a 500% increase in of estrogen-receptor (ER)-negative breast cancers, breast cancer survivors and their caregivers should assess the risks versus benefits and perhaps seek alternative treatments.
New research in the area of homeopathy and botanical medicine shows promise for both cancer prevention and cancer relapse, without the side effects known to be triggered by tamoxifen and other drugs. It is hoped that research in these fields will fill the need for cancer prevention in coming years.
source:- NaturalNews
I am very much delighted. To everyone reading this,i want to inform the public on how i got cured from stage 2 ovarian cancer by Dr Itua Herbal Medicines. i have been suffering from ovarian cancer, and i have also taken treatment from my doctor but no way out,few weeks back i came on the internet to see if i will be able to get any information as to curing Cancers, on my search i saw various testimony of people who was healed from Uterine Cancers and Brain Tumors by the good doctor, called Dr Itua. without any hesitation, i contacted his email: drituaherbalcenter@gmail.com and i wrote him and and he guided me,i asked him for solutions and he started the remedies for me so i started using the medicine, after the period of three weeks given to me by Dr Itua i was completely cured nomore tumors on my body was found anymore. So dear viewer why living your life in therapist or chemo?contact him now on WhatsApp +2348149277967 he is able to cure the listed diseases:Arthritis,Amyotrophic Lateral Scoliosis,Brain Tumor,Fibromyalgia,Pancreative Cancer,Fluoroquinolone ToxicityBladder cancer,Brain cancer,Hiv,Herpes,Esophageal cancer,Kidney cancer,Gallbladder cancer,Gestational trophoblastic disease,Head and neck cancer,Hodgkin lymphoma,Thyroid Cancer,Uterine cancer,Fibroid,Angiopathy, Ataxia,
ReplyDeleteIntestinal cancer,Hpv,Lung cancer,Melanoma,Mesothelioma,Multiple myeloma,Neuroendocrine tumors
Non-Hodgkin lymphoma,Oral cancer,Ovarian cancer,Sinus cancer,Hepatitis,Skin cancer,Soft tissue sarcoma,Spinal cancer,Stomach cancer,Leukemia,Liver cancer,Vaginal cancer,Vulvar cancer,Alzheimer's disease,Chronic Diarrhea,Copd,Parkinson,Als,Adrenocortical carcinoma Infectious mononucleosis.
Testicular cancer,Tach Diseases,Throat cancer,Ocd,
Syndrome Fibrodysplasia Ossificans ProgresSclerosis,